Union Budget 2026: BioPharma Shakti and the Strategic Shift in Indian Healthcare
Frequently Asked Questions
BioPharma Shakti is a national program with an outlay of Rs 10,000 crore over five years, aimed at making India a global hub for biologics and biosimilars manufacturing.
The government announced full basic customs duty exemptions on 17 critical cancer medicines and expanded duty-free personal imports for seven additional rare diseases.
NIMHANS 2.0 will be established in North India, with regional hubs for mental health treatment and research also planned for Ranchi and Tezpur.
The budget aims to train 1.5 lakh multi-skilled caregivers in the next year and add 1 lakh Allied Health Professionals over the next five years.
The budget proposes five regional medical tourism hubs that integrate modern clinical care with AYUSH treatments and advanced rehabilitation services.
A NOTE FROM THE FOUNDER
Hey, I'm Aaditya, founder of Multibagg AI. If you enjoyed reading this article, you've only seen a small part of what's possible with Multibagg AI. Here's what you can do next:
Ask Iris
Get answers from annual reports, concalls, and investor presentations
Discovery
Find hidden gems early using AI-tagged companies
Portfolio
Connect your portfolio and understand what you really own
Timeline
Follow important company updates, filings, deals, and news in one place
It's all about thinking better as an investor. Welcome to a smarter way of doing stock market research.
